188 related articles for article (PubMed ID: 29065397)
1. Immune Therapy of Lympho-Hemopoietic Malignancies.
Echchannaoui H; Theobald M
Oncol Res Treat; 2017; 40(11):652-653. PubMed ID: 29065397
[No Abstract] [Full Text] [Related]
2. Pediatric Acute Lymphoblastic Leukemia.
Rheingold SR
Oncology (Williston Park); 2019 Aug; 33(8):. PubMed ID: 31469898
[No Abstract] [Full Text] [Related]
3. [Bispecific antibodies in onco-hematology: Applications and perspectives].
Barrière S; El-Ghazzi N; Garcia M; Guièze R
Bull Cancer; 2021 Oct; 108(10S):S195-S204. PubMed ID: 34920803
[TBL] [Abstract][Full Text] [Related]
4. Combination epigenetic and immunotherapy overcomes resistance to monoclonal antibodies in hematologic malignancies: A new therapeutic approach.
Epner EM; Saroya BS; Hasanali ZS; Loughran TP
Exp Hematol; 2016 Mar; 44(3):157-60. PubMed ID: 26802532
[TBL] [Abstract][Full Text] [Related]
5. Chimeric antigen receptor T-cell immunotherapy tackles blood cancers.
Brower V
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25838441
[No Abstract] [Full Text] [Related]
6. Clinical trials with blocked ricin immunotoxins.
O'Toole JE; Esseltine D; Lynch TJ; Lambert JM; Grossbard ML
Curr Top Microbiol Immunol; 1998; 234():35-56. PubMed ID: 9670611
[No Abstract] [Full Text] [Related]
7. [Monoclonal antibodies in the treatment of hematological malignancies].
Itälä M
Duodecim; 2002; 118(16):1647-56. PubMed ID: 12271942
[No Abstract] [Full Text] [Related]
8. New immune strategies for the treatment of acute lymphoblastic leukemia: antibodies and chimeric antigen receptors.
Advani AS
Hematology Am Soc Hematol Educ Program; 2013; 2013():131-7. PubMed ID: 24319174
[TBL] [Abstract][Full Text] [Related]
9. Future of Therapy in Acute Lymphoblastic Leukemia (ALL)--Potential Role of Immune-Based Therapies.
Kebriaei P; Poon ML
Curr Hematol Malig Rep; 2015 Jun; 10(2):76-85. PubMed ID: 25899862
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia.
Velardi A; Ruggeri L; Mancusi A; Aversa F; Christiansen FT
Curr Opin Immunol; 2009 Oct; 21(5):525-30. PubMed ID: 19717293
[TBL] [Abstract][Full Text] [Related]
11. Advances in the treatment of hematologic malignancies using immunoconjugates.
Palanca-Wessels MC; Press OW
Blood; 2014 Apr; 123(15):2293-301. PubMed ID: 24578502
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-versus-leukemia, and the problem of extramedullary relapse.
Singhal S; Powles R; Kulkarni S; Treleaven J; Saso R; Mehta J
Leuk Lymphoma; 1999 Feb; 32(5-6):505-12. PubMed ID: 10048423
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal Antibodies, Bispecific Antibodies and Antibody-Drug Conjugates in Oncohematology.
Mihăilă RG
Recent Pat Anticancer Drug Discov; 2020; 15(4):272-292. PubMed ID: 32981510
[TBL] [Abstract][Full Text] [Related]
14. Preparation and identification of a novel immunomodulator composed of muramyl dipeptide and anti-CD10 monoclonal antibody for treatment of minimal residual disease in acute leukemia children.
Wang LZ; Sun LR; Zhao YX; Wang LL
Int Immunopharmacol; 2011 Sep; 11(9):1211-9. PubMed ID: 21492747
[TBL] [Abstract][Full Text] [Related]
15. T cell modulation in immunotherapy for hematological malignancies.
Lin C; Chen S; Li Y
Cell Biol Toxicol; 2017 Aug; 33(4):323-327. PubMed ID: 28474249
[No Abstract] [Full Text] [Related]
16. Use of radiolabeled antibodies in the treatment of childhood acute leukemia.
Nemecek ER; Matthews DC
Pediatr Transplant; 2003; 7 Suppl 3():89-94. PubMed ID: 12603700
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of hematologic malignancies in primary immunodeficiency disorders: opportunities for immunotherapy.
Verhoeven D; Stoppelenburg AJ; Meyer-Wentrup F; Boes M
Clin Immunol; 2018 May; 190():22-31. PubMed ID: 29499421
[TBL] [Abstract][Full Text] [Related]
18. Antibody-targeted chemotherapy of relapsed AML.
Mineur P; Lejeune C; Hennaux V; Eten C
Br J Haematol; 2003 Apr; 121(1):195-6. PubMed ID: 12670356
[No Abstract] [Full Text] [Related]
19. Advances in immunotherapy of hematologic malignancies.
Maloney DG
Curr Opin Hematol; 1998 Jul; 5(4):237-43. PubMed ID: 9747629
[TBL] [Abstract][Full Text] [Related]
20. Advances in immunotherapy of hematologic malignancies: cellular and humoral approaches.
Jurcic JG; Cathcart K; Pinilla-Ibarz J; Scheinberg DA
Curr Opin Hematol; 2000 Jul; 7(4):247-54. PubMed ID: 10882181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
